Naturalmovement.Softer frown lines.Jeuveau neurotoxin in Sherman Oaks

Jeuveau (prabotulinumtoxinA-xvfs) is a prescription botulinum toxin type A product. It is injected into muscles and FDA approved for temporary improvement in the look of moderate to severe frown lines between the eyebrows in adults.

Jeuveau is a neurotoxin, not a dermal filler. It temporarily reduces activity in selected muscles; filler is an injectable implant used for different concerns.

A treatment plan can be designed around a natural-looking goal and the amount of movement you want to preserve. Anatomy, muscle strength, baseline symmetry, dose, and placement all matter. Individual responses vary, so a specific outcome cannot be guaranteed.

In clinical studies cited by the manufacturer, about half of patients began showing at least a one-grade improvement by physician assessment after two days. That measure may not be clinically meaningful for every patient, and full results are assessed later. Timing varies.

Jeuveau results are temporary. The manufacturer presents an actual patient whose results lasted about four months, but duration varies by patient and should not be treated as a guarantee. Retreatment should be discussed with a qualified healthcare professional.

No. Both are botulinum toxin type A prescription products, but they are distinct formulations. Their potency units are product-specific and cannot be directly compared or converted.

Its FDA-approved cosmetic use is the temporary improvement of moderate to severe glabellar lines—often called frown lines or “11 lines”—between the eyebrows in adults. Other uses discussed online may be off-label and require an individualized clinical discussion.